Genomtec S.A.

zł 2.44As of Sun 8 Nov 2026, 12:00 UTC
WSE:GMTHealthcare
Country Poland
PE (Fwd) •••
TSR 6Y CAGR (28.36%)
Div yield —
ROE (55.54%)
Medical Devices
Beta (5Y) 0.43
PE TTM —
TSR TTM (52.52%)
Mkt cap zł 41.72M
ROIC (28.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 3.09
26.33%
(73.18%)
Hold 2|8|2|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.07
0.08
0.08
0.09
31.07%
31.17%
28.93%
37.12%
Revenuezł M
3.993
4.027
4.025
4.233
4.07%
1.88%
3.57%
10.81%
Peers (US$10.54M)
Cap (US$)
PE
8.886M
—
Capital
TTM
5Y
10Y
Leveragex
0.291
(0.055)
(0.051)
EBIT/Intx
9.492
0.095
0.099
Own earn%
61.46
(126.33)
(109.99)
Sh yield%
15.69
43.01
40.08
Owners
Insiders/Inst%
3.66
70.51
Short interest%
1.69
SBC / revenue%
3.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
13